In addition, CXCL12 inhibits DPP4 and accelerates EMT and metastasis in breast cancer,41 and the inhibition of ERBB3 signaling suppresses EMT of hepatocellular carcinoma.42 Here, CXCL12 is linked to hepatocellular carcinoma.